Pathstone Family Office’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-6
Closed -$2K 1486
2020
Q4
$2K Hold
6
﹤0.01% 1063
2020
Q3
$2K Hold
6
﹤0.01% 716
2020
Q2
$3K Hold
6
﹤0.01% 614
2020
Q1
$3K Buy
+6
New +$4.09K ﹤0.01% 677
2019
Q4
Sell
-6
Closed -$2K 677
2019
Q3
$2K Hold
6
﹤0.01% 577
2019
Q2
$2K Hold
6
﹤0.01% 604
2019
Q1
$2K Hold
6
﹤0.01% 825
2018
Q4
$7K Buy
+6
New +$9.52K ﹤0.01% 362

Other funds holding CFRX

Pathstone Family Office's CFRX Position: Q1 2021 in Review

Pathstone Family Office sold out of ContraFect Corporation (CFRX) in Q1 2021, closing a stake of 6 shares — an estimated $2K sold.

Pathstone Family Office first reported a position in CFRX in Q4 2018 and held it in 8 quarters. The position peaked at $7K in Q4 2018. 80 funds tracked by Wall St. Rank hold CFRX as of Q1 2021.

  • Pathstone Family Office reported no remaining ContraFect Corporation position as of Q1 2021 after selling out during the quarter.
  • Pathstone Family Office sold 6 ContraFect Corporation shares in Q1 2021, an estimated $2K.
  • Pathstone Family Office first reported a position in ContraFect Corporation in Q4 2018 and held it in 8 quarters.
  • Pathstone Family Office's ContraFect Corporation position peaked at $7K in Q4 2018.
  • 80 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2021.

Based on Pathstone Family Office's 13F filing for Q1 2021, filed 14 May 2021.